Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Structure Therapeutics Inc.GPCR · Entity 1222 | CHIEF SCIENTIFIC OFFICER | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Structure Therapeutics Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 228,960 |
Ending reported balance
After 2026-09-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 17,817 · Balance 246,777 F1: Reflects price per share in Ordinary Shares. Row 2 · 2026-09-01 · Conversion · Disposed 17,817 · Balance 228,960 F2: The Ordinary Shares were converted into American Depositary Shares as reported in Table II. |
| Share Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.34 · Expires 2029-09-10 | Direct | 125,081 |
Reported balance
After 2026-09-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-01 · Exercise / conversion · Disposed 17,817 · Balance 125,081 F1: Reflects price per share in Ordinary Shares. F3: 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. F4: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 17,817 Ordinary Shares. |
| American Depositary SharesSEC Table II · derivative / convertible security | Direct | 5,939 |
Reported balance
After 2026-09-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-01 · Conversion · Acquired 5,939 · Balance 5,939 F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6: 17,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 5,939 American Depositary Shares. |
| American Depositary SharesSEC Table II · derivative / convertible security | Direct | 4,639 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Sale · Disposed 1,300 · Balance 4,639 F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8: Reflects price per share in American Depositary Shares. F9: The weighted average sale price for the transaction reported was $45.8642 and the range of prices were between $45.63 and $46.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
| American Depositary SharesSEC Table II · derivative / convertible security | Direct | 100 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Sale · Disposed 4,539 · Balance 100 F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8: Reflects price per share in American Depositary Shares. F10: The weighted average sale price for the transaction reported was $47.2030, and the range of prices were between $46.80 and $47.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. |
| American Depositary SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Sale · Disposed 100 · Balance 0 F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8: Reflects price per share in American Depositary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects price per share in Ordinary Shares.
F2: The Ordinary Shares were converted into American Depositary Shares as reported in Table II.
F3: 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F4: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 17,817 Ordinary Shares.
F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
F6: 17,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 5,939 American Depositary Shares.
F7: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026.
F8: Reflects price per share in American Depositary Shares.
F9: The weighted average sale price for the transaction reported was $45.8642 and the range of prices were between $45.63 and $46.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.
F10: The weighted average sale price for the transaction reported was $47.2030, and the range of prices were between $46.80 and $47.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 01:18 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 100 | $47.83 | $4,783.00 |
DisclosureSEC source: 0001962926-26-000009 · form4-09032026_010924.xml · derivative · entry 7 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 100 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 01:18 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 4,539 | $47.20 | $214,254.42 |
DisclosureSEC source: 0001962926-26-000009 · form4-09032026_010924.xml · derivative · entry 6 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100 Underlying: Ordinary Shares · 4,539 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F10 · price: The weighted average sale price for the transaction reported was $47.2030, and the range of prices were between $46.80 and $47.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 01:18 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 1,300 | $45.86 | $59,623.46 |
DisclosureSEC source: 0001962926-26-000009 · form4-09032026_010924.xml · derivative · entry 5 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,639 Underlying: Ordinary Shares · 1,300 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F9 · price: The weighted average sale price for the transaction reported was $45.8642 and the range of prices were between $45.63 and $46.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 01:18 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 5,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000009 · form4-09032026_010924.xml · derivative · entry 4 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,939 Underlying: Ordinary Shares · 5,939 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: 17,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 5,939 American Depositary Shares. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 01:18 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 17,817 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001962926-26-000009 · form4-09032026_010924.xml · derivative · entry 3 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,081 Underlying: Ordinary Shares · 17,817 shares Expires 2029-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects price per share in Ordinary Shares. F3 · derivative.exercise_date: 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. F4 · balance_after: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 17,817 Ordinary Shares. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 01:18 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 17,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000009 · form4-09032026_010924.xml · nonDerivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 01:18 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 17,817 | $0.34 | $6,057.78 |
DisclosureSEC source: 0001962926-26-000009 · form4-09032026_010924.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 246,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects price per share in Ordinary Shares. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:23 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 400 | $55.05 | $22,020.00 |
DisclosureSEC source: 0001962926-26-000008 · form4-08202026_120854.xml · derivative · entry 7 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,200 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F11 · price: The weighted average sale price for the transaction reported was $55.05 and the range of prices were between $54.85 and $55.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:23 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 519 | $54.20 | $28,128.24 |
DisclosureSEC source: 0001962926-26-000008 · form4-08202026_120854.xml · derivative · entry 6 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400 Underlying: Ordinary Shares · 1,557 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F10 · price: The weighted average sale price for the transaction reported was $54.1970, and the range of prices were between $53.80 and $54.7950. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:23 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 3,020 | $53.13 | $160,461.66 |
DisclosureSEC source: 0001962926-26-000008 · form4-08202026_120854.xml · derivative · entry 5 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 919 Underlying: Ordinary Shares · 9,060 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F9 · price: The weighted average sale price for the transaction reported was $53.133 and the range of prices were between $52.77 and $53.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:23 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 3,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000008 · form4-08202026_120854.xml · derivative · entry 4 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,939 Underlying: Ordinary Shares · 11,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: 11,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:23 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 11,817 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001962926-26-000008 · form4-08202026_120854.xml · derivative · entry 3 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,898 Underlying: Ordinary Shares · 11,817 shares Expires 2029-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects price per share in Ordinary Shares. F3 · derivative.exercise_date: 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. F4 · balance_after: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:23 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 11,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000008 · form4-08202026_120854.xml · nonDerivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:23 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 11,817 | $0.34 | $4,017.78 |
DisclosureSEC source: 0001962926-26-000008 · form4-08202026_120854.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects price per share in Ordinary Shares. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:49 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 839 | $50.03 | $41,974.33 |
DisclosureSEC source: 0001962926-26-000007 · form4-08052026_080829.xml · derivative · entry 6 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,517 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F10 · price: The weighted average sale price for the transaction reported was $50.0290, and the range of prices were between $49.69 and $50.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:49 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 3,100 | $49.29 | $152,785.67 |
DisclosureSEC source: 0001962926-26-000007 · form4-08052026_080829.xml · derivative · entry 5 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 839 Underlying: Ordinary Shares · 9,300 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F9 · price: The weighted average sale price for the transaction reported was $49.2857 and the range of prices were between $48.66 and $49.65. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:49 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 3,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000007 · form4-08052026_080829.xml · derivative · entry 4 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,939 Underlying: Ordinary Shares · 11,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: 11,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:49 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 11,817 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001962926-26-000007 · form4-08052026_080829.xml · derivative · entry 3 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,715 Underlying: Ordinary Shares · 11,817 shares Expires 2029-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects price per share in Ordinary Shares. F3 · derivative.exercise_date: 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. F4 · balance_after: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:49 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 11,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000007 · form4-08052026_080829.xml · nonDerivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 20:49 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 11,817 | $0.34 | $4,017.78 |
DisclosureSEC source: 0001962926-26-000007 · form4-08052026_080829.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects price per share in Ordinary Shares. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 22:57 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 1,600 | $51.71 | $82,734.08 |
DisclosureSEC source: 0001962926-26-000006 · form4-07152026_100751.xml · derivative · entry 6 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,800 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F10 · price: The weighted average sale price for the transaction reported was $51.7088, and the range of prices were between $51.32 and $52.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 22:57 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 6,278 | $50.80 | $318,894.78 |
DisclosureSEC source: 0001962926-26-000006 · form4-07152026_100751.xml · derivative · entry 5 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,600 Underlying: Ordinary Shares · 18,834 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F9 · price: The weighted average sale price for the transaction reported was $50.7956 and the range of prices were between $50.31 and $51.30. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 22:57 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 7,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000006 · form4-07152026_100751.xml · derivative · entry 4 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,878 Underlying: Ordinary Shares · 23,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: 23,634 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 7,878 American Depositary Shares. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 22:57 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 23,634 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001962926-26-000006 · form4-07152026_100751.xml · derivative · entry 3 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,532 Underlying: Ordinary Shares · 23,634 shares Expires 2029-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects price per share in Ordinary Shares. F3 · derivative.exercise_date: 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. F4 · balance_after: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 23,634 Ordinary Shares. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 22:57 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 23,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000006 · form4-07152026_100751.xml · nonDerivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 22:57 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 23,634 | $0.34 | $8,035.56 |
DisclosureSEC source: 0001962926-26-000006 · form4-07152026_100751.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects price per share in Ordinary Shares. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 00:32 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 7,878 | $49.08 | $386,645.94 |
DisclosureSEC source: 0001962926-26-000005 · form4-06302026_120631.xml · derivative · entry 5 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 23,634 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F7 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026. F8 · price: Reflects price per share in American Depositary Shares. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 00:32 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 7,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000005 · form4-06302026_120631.xml · derivative · entry 4 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,878 Underlying: Ordinary Shares · 23,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: 23,634 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 7,878 American Depositary Shares. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 00:32 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 23,634 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001962926-26-000005 · form4-06302026_120631.xml · derivative · entry 3 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,166 Underlying: Ordinary Shares · 23,634 shares Expires 2029-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects price per share in Ordinary Shares. F3 · derivative.exercise_date: 1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. F4 · balance_after: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 23,634 Ordinary Shares. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 00:32 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 23,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000005 · form4-06302026_120631.xml · nonDerivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II. Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 00:32 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 23,634 | $0.34 | $8,035.56 |
DisclosureSEC source: 0001962926-26-000005 · form4-06302026_120631.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects price per share in Ordinary Shares. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 20:30 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantEmployee Stock Option (right to buy) · Derivative | 53,703 | $0.00 Strike: $16.82 | $0.00 |
DisclosureSEC source: 0001962926-26-000003 · form4-03232026_040305.xml · derivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,703 Underlying: Ordinary Shares · 53,703 shares Expires 2036-03-18 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 20:30 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 43,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001962926-26-000003 · form4-03232026_040305.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,960 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:20 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 18,735 | $20.99 | $393,247.65 |
DisclosureSEC source: 0001962926-26-000002 · form4-03052026_060307.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,592 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 21:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 57,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019352 · form4-07032025_050706.xml · nonDerivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,173 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F3 · kind: On March 15, 2024, the reporting person was granted performance-vesting restricted share units ("PSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date. Read SEC document |
| July 01, 2025 Filed Aug 20, 2025 21:00 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 12,846 | $6.84 | $87,822.96 |
DisclosureSEC source: 0001415889-25-022471 · form4-08202025_050801.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,327 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantEmployee Stock Option (right to buy) · Derivative | 196,386 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008552 · form4-03182025_080306.xml · derivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,386 Underlying: Ordinary Shares · 196,386 shares Expires 2035-03-15 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 80,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008552 · form4-03182025_080306.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,536 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 21:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 6,441 | $7.92 | $50,990.82 |
DisclosureSEC source: 0001415889-25-019352 · form4-07032025_050706.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,095 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 17,700 | $50.00 | $885,070.80 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 6 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 53,100 shares Expires not disclosed F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. F7 · price: The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 17,700 | $45.00 | $796,500.00 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 5 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,700 Underlying: Ordinary Shares · 53,100 shares Expires not disclosed F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023. F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 35,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 4 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,400 Underlying: Ordinary Shares · 106,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · shares: 106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares. F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 106,200 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 3 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,800 Underlying: Ordinary Shares · 106,200 shares Expires 2029-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. F3 · balance_after: This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 106,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · nonDerivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II above. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 23:38 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 106,200 | $0.34 | $36,108.00 |
DisclosureSEC source: 0001415889-24-015683 · form4-06052024_110646.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:51 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantStock Option (right to buy) · Derivative | 213,486 | $0.00 Strike: $35.25 | $0.00 |
DisclosureSEC source: 0001415889-24-008572 · form4-03192024_080311.xml · derivative · entry 2 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,486 Underlying: Ordinary Shares · 213,486 shares Expires 2034-03-14 F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:51 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 85,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008572 · form4-03192024_080311.xml · nonDerivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,707 F1 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 15, 2024 Filed Mar 20, 2024 23:42 UTC Amendment | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantStock Option (right to buy) · Derivative | 213,486 | $0.00 Strike: $11.75 | $0.00 |
DisclosureSEC source: 0001415889-24-008784 · form4a-03202024_110328.xml · derivative · entry 1 Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,486 Underlying: Ordinary Shares · 213,486 shares Expires 2034-03-14 F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price as that of the Ordinary Shares rather than the American Depositary Shares ("ADSs"). The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F3 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.